Clinical Trials Directory

Trials / Completed

CompletedNCT03712891

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
178 (actual)
Sponsor
TriHealth Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).

Detailed description

Decreasing the length of stay in PACU for surgical patient is a pertinent outcome. The shorter length of stay can achieve higher patient engagement scores, while simultaneously increasing the productivity of the unit. This is achieved by making more beds available for new patients coming from the operating room (OR). One thought was that coffee would benefit the investigator's patients experience through a number of pathways. Initially, the stimulant effect of coffee would create a more alert patient. A more alert patient is more likely to comprehend home care instruction and be ready for discharge earlier. Coffee is often used as a remedy for morning sickness. Ideally the act of drinking coffee or even smelling the coffee may decrease the occurrence of Post-Operative Nausea and Vomiting (PONV) in investigator's patient population. Finally, patients frequently state that the inability to drink their morning coffee is often more difficult than not being able to eat prior to surgery. By allowing those to drink coffee in PACU this would make the patient feel that they are being cared for on an emotional level, in addition to a physical level.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCoffeePatients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)

Timeline

Start date
2018-10-25
Primary completion
2023-07-01
Completion
2023-08-16
First posted
2018-10-19
Last updated
2024-12-13
Results posted
2024-12-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03712891. Inclusion in this directory is not an endorsement.